在BRCA1/2-缺陷细胞中,UFL1触发了MRE11的复制叉降解
Tian Tian1,2, Junliang Chen3, Huacun Zhao4
1Zhejiang Key Laboratory of Geriatrics and Geriatrics Institute of Zhejiang Province, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Nature chemical biology
|April 22, 2024
概括
在BRCA1/2缺乏瘤中,UFL1稳定了停滞不前的复制分叉,为PARP抑制剂提供了耐药性. 它的PTIP UFMylation损失或中断保护DNA并增强治疗耐药性.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 遗传学 是一个遗传学.
背景情况:
- 复制叉的稳定性对于预防癌症中的基因组不稳定性至关重要.
- 在BRCA1/2-缺陷瘤中对多聚酸基聚合酶 (PARP) 抑制剂的耐药性通常由稳定停滞的复制分叉的机制介导.
- 了解这些抵抗机制对于开发有效的癌症疗法至关重要.
研究的目的:
- 在PARP抑制剂耐药性的背景下,确定复制叉稳定性的关键调节者.
- 阐明UFL1影响叉稳定性和PARP抑制剂反应的分子机制.
- 探索潜在的治疗点,以克服BRCA1/2-缺陷癌症中的PARP抑制剂耐药性.
主要方法:
- 利用基于细胞的测试来研究在复制压力下复制叉动态.
- 采用生物化学技术,包括免疫沉和西式涂抹,以研究蛋白质相互作用和修饰.
- 分析了UFL1,UFMylation和PTIP修饰在调节DNA链完整性和PARP抑制剂敏感性的作用.
主要成果:
- 鉴定了UFL1,一种UFM1特异性的E3结合酶,作为BRCA1/2缺乏细胞分叉稳定的关键调节剂.
- 证明UFL1在停滞的分叉中催化PTIP UFMylation,促进MLL3/4复合体组装和H3K4甲基化.
- 表明UFL1的丧失,PTIP UFMylation受损或UFSP2过度表达保护新生DNA免受降解,并赋予对PARP抑制剂的耐药性.
结论:
- UFL1-介导的PTIP UFMylation是一种新的机制,可以稳定停滞不前的复制分叉,并驱动BRCA1/2-缺乏瘤中的PARP抑制剂耐药性.
- 针对UFL1-PTIP轴可以提供一种策略,使BRCA1/2-缺乏瘤对PARP抑制剂敏感.
- 这些发现为治疗耐药性提供了关键的机制性见解,并为癌症治疗提供了新的途径.
相关概念视频
02:37Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
01:02The DNA Replication Fork
35.9K
An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork. Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
35.9K
02:31Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K
01:02Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
01:08Nucleotide Excision Repair
37.0K
Overview
37.0K
02:37DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K